Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;47(12):1895-1904.
doi: 10.1002/cbin.12094. Epub 2023 Oct 9.

The role of NFATc1 in the progression and metastasis of prostate cancer: A review on the molecular mechanisms and signaling pathways

Affiliations
Review

The role of NFATc1 in the progression and metastasis of prostate cancer: A review on the molecular mechanisms and signaling pathways

Samaneh Hasani et al. Cell Biol Int. 2023 Dec.

Abstract

A common type of cancer among men is the prostate cancer that kills many people every year. The multistage of this disease and the involvement of the vital organs of the body have reduced the life span and quality of life of the people involved and turned the treatment process into a complex one. NFATc1 biomarker contributes significantly in the diagnosis and treatment of this disease by increasing its expression in prostate cancer and helping the proliferation, differentiation, and invasion of cancer cells through different signaling pathways. NFATc1 is also able to target the metabolism of cancer cells by inserting specific oncogene molecules such as c-myc that it causes cell growth and proliferation. Bone is a common tissue where prostate cancer cells metastasize. In this regard, the activity of NFATc1, through the regulation of different signaling cascades, including the RANKL/RANK signaling pathway, in turn, increases the activity of osteoclasts, and as a result, bone tissue is gradually ruined. Using Silibinin as a medicinal plant extract can inhibit the activity of osteoclasts related to prostate cancer by targeting NFATc. Undoubtedly, NFATc1 is one of the effective oncogenes related to prostate cancer, which has the potential to put this cancer on the path of progression and metastasis. In this review, we will highlight the role of NFATc1 in the progression and metastasis of prostate cancer. Furthermore, we will summarize signaling pathways and molecular mechanism, through which NFATc1 regulates the process of prostate cancer.

Keywords: bone metastasis; cancer; protein signaling modules/scaffolds.

PubMed Disclaimer

References

REFERENCES

    1. Aapro, M., Saad, F., & Costa, L. (2010). Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. The oncologist, 15, 1147-1158.
    1. Agarwal, R., Agarwal, C., Ichikawa, H., Singh, R. P., & Aggarwal, B. B. (2006). Anticancer potential of silymarin: From bench to bed side. Anticancer Research, 26, 4457-4498.
    1. Alizadeh-Fanalou, S., Hosseinkhani, S., Nazarizadeh, A., Ezzati-Mobaser, S., Hesari, Z., Aziminezhadan, P., Abdolvahabi, Z., Abolmaali, M., Tavakoli-Yaraki, M., & Nourbakhsh, M. (2021). MiR-613 promotes cell death in breast cancer cells by downregulation of nicotinamide phosphoribosyltransferase and reduction of NAD. DNA and Cell Biology, 40, 1026-1036.
    1. Ansari, A. A. (2004). Autoimmunity, anergy, lentiviral immunity and disease. Autoimmunity Reviews, 3, 530-540.
    1. Aramburu, J., Heitman, J., & Crabtree, G. R. (2004). Calcineurin: A central controller of signalling in eukaryotes. EMBO Reports, 5, 343-348.

LinkOut - more resources